boryung pharmaceutical co
(003850:Korea SE)

Financial Statements for boryung pharmaceutical co (003850)

Currency in Millions of South Korean Wons	As of:	Dec 31 2009 KRW	Dec 31 2010 Press Release KRW	Dec 31 2011 Press Release KRW	Dec 31 2012 KRW	4 Year Trend
Revenues		245,941.1	300,958.9	308,005.5	312,075.0
TOTAL REVENUES		267,844.3	300,958.9	308,005.5	312,075.0
Cost of Goods Sold		159,419.3	179,632.7	181,638.9	185,733.5
GROSS PROFIT		108,425.0	121,326.2	126,366.6	126,341.5
Selling General & Admin Expenses, Total		76,461.4	85,469.3	94,295.3	93,322.1
R&D Expenses		17,519.5	17,341.6	25,556.4	28,226.1
Depreciation & Amortization, Total		2,519.4	--	--	1,744.0
Other Operating Expenses		1,746.8	--	--	--
OTHER OPERATING EXPENSES, TOTAL		98,247.2	102,810.9	119,851.7	123,292.2
OPERATING INCOME		10,177.8	18,515.3	6,514.9	3,049.3
Interest Expense		-415.4	-1,902.6	-2,419.9	-2,441.0
Interest and Investment Income		336.6	128.3	128.0	160.3
Other Non-Operating Expenses, Total		-806.6	2,492.7	3,267.3	4,479.3
Other Non-Operating Income (Expenses)		-53.4	2,492.7	3,267.3	4,442.6
Gain (Loss) on Sale of Investments		-45.4	--	--	--
Gain (Loss) on Sale of Assets		3.0	--	--	105.0
EBT, INCLUDING UNUSUAL ITEMS		9,250.0	19,233.8	7,490.3	5,352.9
Income Tax Expense		4,067.9	4,884.7	1,312.2	-4,048.1
Earnings from Continuing Operations		5,182.2	14,349.1	6,178.1	9,401.0
NET INCOME		5,182.2	14,349.1	6,178.1	9,401.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS		5,182.2	14,349.1	6,178.1	9,401.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS		5,182.2	14,349.1	6,178.1	9,401.0

Report Data Issue

To contact BORYUNG PHARMACEUTICAL CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.